The re-emergence of the GP73 and fucosylated liver cancer biomarkers
摘要
The study shows that GP73 alone may not be sufficient to achieve the discrimination in every population. This is because many other clinical factors may influence the levels of the biomarker. This review attempts to identify some of these clinical variables,and helps provide a means of using these clinical values,in combination with GP73,to achieve the best use of the entire clinical biomarker family.
引用本文（GB/T 7714）
Timothy Timothy. The re-emergence of the GP73 and fucosylated liver cancer biomarkers[J]. 中国工程科学：英文版, 2014.
引文网络
本站仅收录题录与摘要供学习参考，全文版权归属出版方；如有侵权请联系我们删除。